On the Call: Merck CEO Kenneth C. Frazier
Apr 27, 2012 | Posted by: roboblogger | Full story: CBS News
Drugmaker Merck & Co., discussing its first-quarter results, said it will apply for approval by the end of 2013 for five new products, including a new type of drug to fight bone-thinning osteoporosis, odanacatib.
I think people can see this as justice especially of they are affected of the Fosamax situation because it should have been his duty as CEO to look over things in the company.
Considering the things that came up with Fosamax and how they handles it, I am now very careful about using any Merck products especially the new ones. http://www.fosamaxfemurfracturelawsuit.com
The new osteoporosis drug from Merck and Co. is indeed promising. However, as were any medication, there may be no full guarantee that the upcoming drug won't have reports of side effects. As with Fosamax, reports have adverse events are still piling up. For additional information visit http://www.fosamax-lawsuit.net
5 Users are viewing the Healthcare Industry Forum right now
|Child dies after accident involving plow truck ...||50 min||Mysticreality77||48|
|Merck's MSD Pharma to create 800 jobs in India (Nov '08)||Sat||Jitendra Kumar Kushwaha||210|
|4 arrested on murder charges: Authorities say r... (Feb '11)||Fri||ericko||186|
|Community healing and a forward vision||Dec 5||Estes Park Resident||5|
|Obama announces $100 million initiative at Nati...||Dec 4||rajuarun||1|
|J&J Failed to Warn of Vaginal Mesh Risks, Jury ... (Mar '13)||Dec 2||jacobgabriel001||7|
|Verdict: $3.35 Million Awarded in Vaginal Mesh ... (Mar '13)||Dec 2||jacobgabriel001||3|